Amgen Pre-Tax Profit Margin 2011-2025 | AMGN

Current and historical pre-tax profit margin for Amgen (AMGN) from 2011 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Amgen pre-tax profit margin for the three months ending September 30, 2025 was .
Amgen Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-09-30 $35.97B $8.24B 22.92%
2025-06-30 $34.92B $7.42B 21.26%
2025-03-31 $34.13B $6.65B 19.49%
2024-12-31 $33.42B $4.61B 13.79%
2024-09-30 $32.53B $4.68B 14.38%
2024-06-30 $30.93B $3.53B 11.40%
2024-03-31 $29.53B $4.35B 14.71%
2023-12-31 $28.19B $7.86B 27.86%
2023-09-30 $26.83B $8.75B 32.61%
2023-06-30 $26.58B $9.20B 34.59%
2023-03-31 $26.19B $9.11B 34.80%
2022-12-31 $26.32B $7.35B 27.91%
2022-09-30 $26.33B $7.73B 29.35%
2022-06-30 $26.38B $7.49B 28.40%
2022-03-31 $26.32B $6.52B 24.77%
2021-12-31 $25.98B $6.70B 25.79%
2021-09-30 $25.77B $6.45B 25.02%
2021-06-30 $25.48B $6.50B 25.50%
2021-03-31 $25.16B $7.97B 31.67%
2020-12-31 $25.42B $8.13B 31.99%
2020-09-30 $24.99B $8.24B 32.97%
2020-06-30 $24.30B $8.31B 34.20%
2020-03-31 $23.97B $8.84B 36.90%
2019-12-31 $23.36B $9.14B 39.11%
2019-09-30 $23.40B $9.34B 39.92%
2019-06-30 $23.56B $9.16B 38.86%
2019-03-31 $23.75B $9.24B 38.91%
2018-12-31 $23.75B $9.55B 40.19%
2018-09-30 $23.32B $9.57B 41.06%
2018-06-30 $23.19B $9.86B 42.53%
2018-03-31 $22.94B $9.76B 42.53%
2017-12-31 $22.85B $9.60B 42.00%
2017-09-30 $23.01B $9.67B 42.00%
2017-06-30 $23.05B $9.70B 42.10%
2017-03-31 $22.93B $9.37B 40.85%
2016-12-31 $22.99B $9.16B 39.85%
2016-09-30 $22.56B $8.79B 38.97%
2016-06-30 $22.47B $8.57B 38.12%
2016-03-31 $22.16B $8.36B 37.73%
2015-12-31 $21.66B $7.98B 36.83%
2015-09-30 $21.46B $7.35B 34.26%
2015-06-30 $20.77B $6.50B 31.28%
2015-03-31 $20.58B $6.26B 30.41%
2014-12-31 $20.06B $5.59B 27.84%
2014-09-30 $19.74B $5.31B 26.91%
2014-06-30 $19.46B $5.48B 28.16%
2014-03-31 $18.96B $5.13B 27.04%
2013-12-31 $18.68B $5.27B 28.19%
2013-09-30 $18.09B $5.17B 28.61%
2013-06-30 $17.66B $4.93B 27.94%
2013-03-31 $17.46B $4.99B 28.56%
2012-12-31 $17.27B $5.01B 29.01%
2012-09-30 $16.82B $5.14B 30.55%
2012-06-30 $16.44B $4.33B 26.32%
2012-03-31 $15.92B $4.21B 26.44%
2011-12-31 $15.58B $4.15B 26.63%
2011-09-30 $15.45B $4.10B 26.52%
2011-06-30 $15.32B $5.08B 33.14%
2011-03-31 $15.17B $5.20B 34.30%
2010-12-31 $15.05B $5.32B 35.32%
2010-09-30 $15.02B $5.39B 35.90%
2010-06-30 $15.02B $5.50B 36.62%
2010-03-31 $14.93B $5.39B 36.12%
2009-12-31 $14.64B $5.20B 35.54%
2009-09-30 $14.58B $5.22B 35.81%
2009-06-30 $14.65B $5.09B 34.78%
2009-03-31 $14.70B $4.87B 33.11%
2008-12-31 $15.00B $5.02B 33.43%
2008-09-30 $15.00B $4.81B 32.09%
2008-06-30 $14.73B $3.77B 25.60%
2008-03-31 $14.70B $3.78B 25.71%
2007-12-31 $14.77B $3.79B 25.68%
2007-09-30 $14.86B $3.93B 26.46%
2007-06-30 $14.86B $4.92B 33.11%
2007-03-31 $14.74B $4.10B 27.82%
2006-12-31 $14.27B $4.02B 28.17%
2006-09-30 $13.70B $4.10B 29.93%
2006-06-30 $13.25B $4.05B 30.60%
2006-03-31 $12.81B $5.04B 39.30%
2005-12-31 $12.43B $4.87B 39.16%
2005-09-30 $12.07B $4.68B 38.76%
2005-06-30 $11.63B $3.87B 33.32%
2005-03-31 $11.04B $3.59B 32.54%
2004-12-31 $10.55B $3.40B 32.18%
2004-09-30 $9.99B $3.25B 32.49%
2004-06-30 $9.48B $3.60B 37.99%
2004-03-31 $8.94B $3.43B 38.42%
2003-12-31 $8.36B $3.17B 37.97%
2003-09-30 $7.78B $3.07B 39.51%
2003-06-30 $7.07B $-0.24B -3.40%
2003-03-31 $6.28B $-0.49B -7.82%
2002-12-31 $5.52B $-0.69B -12.40%
2002-09-30 $4.88B $-1.11B -22.80%
2002-06-30 $4.39B $1.83B 41.76%
2002-03-31 $4.12B $1.72B 41.69%
2001-12-31 $4.02B $1.69B 41.98%
2001-09-30 $3.84B $1.77B 45.93%
2001-06-30 $3.79B $1.80B 47.41%
2001-03-31 $3.72B $1.75B 47.11%
2000-12-31 $3.63B $1.68B 46.16%
2000-09-30 $3.61B $1.74B 48.27%
2000-06-30 $3.50B $1.66B 47.49%
2000-03-31 $3.41B $1.61B 47.08%
1999-12-31 $3.34B $1.57B 46.87%
1999-09-30 $3.17B $1.51B 47.55%
1999-06-30 $3.02B $1.38B 45.52%
1999-03-31 $2.86B $1.30B 45.58%
1998-12-31 $2.72B $1.23B 45.07%
1998-09-30 $2.57B $1.14B 44.47%
1998-06-30 $2.47B $0.91B 36.85%
1998-03-31 $2.43B $0.88B 36.12%
1997-12-31 $2.40B $0.86B 35.80%
1997-09-30 $2.39B $0.86B 36.12%
1997-06-30 $2.36B $1.02B 43.43%
1997-03-31 $2.31B $1.01B 43.54%
1996-12-31 $2.24B $0.96B 42.95%
1996-09-30 $2.16B $0.93B 42.96%
1996-06-30 $2.09B $0.89B 42.81%
1996-03-31 $2.01B $0.84B 41.81%
1995-12-31 $1.94B $0.80B 40.98%
1995-09-30 $1.87B $0.66B 35.37%
1995-06-30 $1.80B $0.63B 35.07%
1995-03-31 $1.72B $0.60B 34.76%
1994-12-31 $1.65B $0.59B 35.68%
1994-09-30 $1.57B $0.66B 41.76%
1994-06-30 $1.50B $0.62B 41.40%
1994-03-31 $1.43B $0.61B 42.72%
1993-12-31 $1.37B $0.59B 43.01%
1993-09-30 $1.32B $0.65B 49.62%
1993-06-30 $1.26B $0.65B 51.27%
1993-03-31 $1.18B $0.60B 50.76%
1992-12-31 $1.09B $0.56B 51.65%
1992-09-30 $0.99B $0.45B 45.29%
1992-06-30 $0.86B $0.38B 44.16%
1992-03-31 $0.73B $0.20B 26.95%
1991-12-31 $0.65B $0.16B 24.50%
1991-09-30 $0.43B $0.02B 5.12%
1991-06-30 $0.33B $-0.03B -9.64%
1991-03-31 $0.26B $0.05B 19.77%
1990-12-31 $0.13B $0.01B 4.51%
1990-09-30 $0.13B $0.06B 48.80%
1990-06-30 $0.08B $0.05B 54.22%
1990-03-31 $0.03B $0.03B 90.91%
1989-12-31 $0.00B $0.02B -566.67%
1989-09-30 $0.01B $-0.01B -45.45%
1989-06-30 $-0.01B $-0.01B 142.86%
1989-03-31 $-0.01B $-0.01B 157.14%
1988-12-31 $0.04B $-0.01B -21.62%
1988-09-30 $0.05B $0.00B 5.56%
1988-06-30 $0.05B $0.00B 4.00%
1988-03-31 $0.04B $0.00B 4.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $186.002B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $281.765B 19.88
Gilead Sciences (GILD) United States $155.085B 15.26
Vertex Pharmaceuticals (VRTX) United States $117.505B 30.25
Bristol Myers Squibb (BMY) United States $103.742B 7.77
GSK (GSK) United Kingdom $99.429B 11.05
Regeneron Pharmaceuticals (REGN) United States $76.057B 19.73
Alnylam Pharmaceuticals (ALNY) United States $62.528B 2057.78
CSL (CSLLY) Australia $58.655B 0.00
Argenex SE (ARGX) Netherlands $56.754B 70.47
Insmed (INSM) United States $44.101B 0.00
Novozymes (NVZMY) Denmark $28.477B 0.00
Biogen (BIIB) United States $26.516B 10.80
Royalty Pharma (RPRX) United States $22.859B 8.76
BioNTech SE (BNTX) Germany $21.782B 0.00
Genmab (GNMSF) Denmark $20.751B 15.22
Genmab (GMAB) Denmark $20.351B 15.30
Incyte (INCY) United States $19.927B 19.08
Illumina (ILMN) United States $19.551B 29.35
Exact Sciences (EXAS) United States $19.184B 532.90
Revolution Medicines (RVMD) United States $15.019B 0.00
Roivant Sciences (ROIV) United Kingdom $14.397B 0.00
Guardant Health (GH) United States $13.355B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $12.549B 23.34
Ascendis Pharma (ASND) Denmark $12.370B 0.00
Exelixis (EXEL) United States $11.800B 18.89
Avidity Biosciences (RNA) United States $10.785B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.434B 18.92
QIAGEN (QGEN) Netherlands $10.408B 19.75
Jazz Pharmaceuticals (JAZZ) Ireland $10.154B 39.60
Bio-Techne Corp (TECH) United States $9.944B 37.10
Moderna (MRNA) United States $9.839B 0.00
Repligen (RGEN) United States $9.374B 100.31
Arrowhead Pharmaceuticals (ARWR) United States $8.838B 0.00
Abivax SA (ABVX) France $8.634B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.381B 30.14
Cytokinetics (CYTK) United States $7.906B 0.00
Nuvalent (NUVL) United States $7.772B 0.00
Halozyme Therapeutics (HALO) United States $7.604B 12.15
Axsome Therapeutics (AXSM) United States $7.451B 0.00
Merus (MRUS) Netherlands $7.290B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.983B 0.00
Cidara Therapeutics (CDTX) United States $6.947B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.433B 0.00
Krystal Biotech (KRYS) United States $6.306B 32.60
Vaxcyte (PCVX) United States $6.244B 0.00
PTC Therapeutics (PTCT) United States $6.083B 8.26
Cogent Biosciences (COGT) United States $5.575B 0.00
Zealand Pharma (ZLDPF) Denmark $5.480B 5.55
Protagonist Therapeutics (PTGX) United States $5.381B 138.82
CRISPR Therapeutics AG (CRSP) Switzerland $5.336B 0.00
Belite Bio (BLTE) United States $5.296B 0.00
Legend Biotech (LEGN) United States $5.125B 0.00
Apogee Therapeutics (APGE) United States $5.093B 0.00
TG Therapeutics (TGTX) United States $5.018B 11.37
Anbio Biotechnology (NNNN) Germany $4.967B 0.00
Alkermes (ALKS) Ireland $4.876B 14.34
Kymera Therapeutics (KYMR) United States $4.748B 0.00
ADMA Biologics Inc (ADMA) United States $4.693B 33.42
Praxis Precision Medicines (PRAX) United States $4.655B 0.00
Celcuity (CELC) United States $4.627B 0.00
Akero Therapeutics (AKRO) United States $4.502B 0.00
Scholar Rock Holding (SRRK) United States $4.438B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.378B 36.97
Arcellx (ACLX) United States $4.218B 0.00
Viking Therapeutics (VKTX) United States $4.003B 0.00
Immunovant (IMVT) United States $3.981B 0.00
GRAIL (GRAL) United States $3.945B 0.00
Ligand Pharmaceuticals (LGND) United States $3.799B 93.25
Arcutis Biotherapeutics (ARQT) United States $3.670B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.648B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.517B 0.00
Disc Medicine (IRON) United States $3.487B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.476B 0.00
CG Oncology (CGON) United States $3.437B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.423B 0.00
Telix Pharmaceuticals (TLX) Australia $3.272B 0.00
Travere Therapeutics (TVTX) United States $3.118B 0.00
Mineralys Therapeutics (MLYS) United States $3.102B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.077B 90.20
Amicus Therapeutics (FOLD) United States $3.017B 244.50
IDEAYA Biosciences (IDYA) United States $3.010B 0.00
Viridian Therapeutics (VRDN) United States $2.987B 0.00
Liquidia (LQDA) United States $2.935B 0.00
Nuvation Bio (NUVB) United States $2.870B 0.00
Ascentage Pharma Group - (AAPG) China $2.831B 0.00
Denali Therapeutics (DNLI) United States $2.787B 0.00
Arcus Biosciences (RCUS) United States $2.767B 0.00
Beam Therapeutics (BEAM) United States $2.713B 0.00
Apellis Pharmaceuticals (APLS) United States $2.689B 68.55
Vera Therapeutics (VERA) United States $2.638B 0.00
Adaptive Biotechnologies (ADPT) United States $2.615B 0.00
Spyre Therapeutics (SYRE) United States $2.498B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.487B 0.00
Terns Pharmaceuticals (TERN) United States $2.476B 0.00
Edgewise Therapeutics (EWTX) United States $2.469B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.426B 0.00
Bavarian Nordic (BVNRY) Denmark $2.325B 6.31
Sarepta Therapeutics (SRPT) United States $2.289B 0.00
Jyong Biotech (MENS) Taiwan $2.224B 0.00
Zai Lab (ZLAB) China $2.211B 0.00
Mesoblast (MESO) Australia $2.172B 0.00
ImmunityBio (IBRX) United States $2.167B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.131B 11.64
Maze Therapeutics (MAZE) United States $1.996B 0.00
Zenas BioPharma (ZBIO) United States $1.968B 0.00
Zymeworks (ZYME) United States $1.962B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.914B 0.00
Twist Bioscience (TWST) United States $1.906B 0.00
Vericel (VCEL) United States $1.891B 155.79
Dianthus Therapeutics (DNTH) United States $1.885B 0.00
Olema Pharmaceuticals (OLMA) United States $1.871B 0.00
ANI Pharmaceuticals (ANIP) United States $1.858B 14.40
Celldex Therapeutics (CLDX) United States $1.848B 0.00
Sionna Therapeutics (SION) United States $1.837B 0.00
Structure Therapeutics (GPCR) United States $1.827B 0.00
Immunome (IMNM) United States $1.776B 0.00
Stoke Therapeutics (STOK) United States $1.768B 46.21
Trevi Therapeutics (TRVI) United States $1.757B 0.00
MannKind (MNKD) United States $1.717B 55.90
Syndax Pharmaceuticals (SNDX) United States $1.713B 0.00
Agios Pharmaceuticals (AGIO) United States $1.603B 0.00
UniQure (QURE) Netherlands $1.587B 0.00
NeoGenomics (NEO) United States $1.568B 0.00
Certara (CERT) United States $1.542B 28.47
Pharvaris (PHVS) Netherlands $1.536B 0.00
MBX Biosciences (MBX) United States $1.524B 0.00
Atai Beckley N.V (ATAI) Netherlands $1.475B 0.00
Upstream Bio (UPB) United States $1.457B 0.00
Alvotech (ALVO) Luxembourg $1.399B 20.17
Fortrea Holdings (FTRE) United States $1.347B 28.59
Rapport Therapeutics (RAPP) United States $1.323B 0.00
NovoCure (NVCR) Jersey $1.323B 0.00
Nurix Therapeutics (NRIX) United States $1.294B 0.00
Tango Therapeutics (TNGX) United States $1.289B 0.00
Dynavax Technologies (DVAX) United States $1.288B 37.83
Precigen (PGEN) United States $1.263B 0.00
Immatics (IMTX) Germany $1.257B 0.00
Kodiak Sciences (KOD) United States $1.218B 0.00
AnaptysBio (ANAB) United States $1.212B 0.00
Inhibrx Biosciences (INBX) United States $1.207B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.202B 0.00
WAVE Life Sciences (WVE) Singapore $1.194B 0.00
Sana Biotechnology (SANA) United States $1.191B 0.00
Septerna (SEPN) United States $1.189B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.176B 0.00
Tyra Biosciences (TYRA) United States $1.158B 0.00
CureVac (CVAC) Germany $1.158B 0.00
Castle Biosciences (CSTL) United States $1.150B 157.64
Urogen Pharma (URGN) United States $1.140B 0.00
Novavax (NVAX) United States $1.111B 2.83
Pharming Group (PHGUF) Netherlands $1.107B 165.00
Monte Rosa Therapeutics (GLUE) United States $1.098B 52.69
Palvella Therapeutics (PVLA) United States $1.088B 0.00
Pharming Group (PHAR) Netherlands $1.083B 0.00
Oric Pharmaceuticals (ORIC) United States $1.069B 0.00
Intellia Therapeutics (NTLA) United States $1.049B 0.00
AbCellera Biologics (ABCL) Canada $1.045B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.044B 0.00
Kura Oncology (KURA) United States $1.042B 0.00
Pacira BioSciences (PCRX) United States $1.041B 11.92
MiMedx (MDXG) United States $1.031B 18.32
Janux Therapeutics (JANX) United States $1.029B 0.00
Nanobiotix S.A - (NBTX) France $1.008B 0.00
Bicara Therapeutics (BCAX) United States $0.995B 0.00
Oculis Holding AG (OCS) Switzerland $0.995B 0.00
Biohaven (BHVN) United States $0.965B 0.00
ArriVent BioPharma (AVBP) United States $0.945B 0.00
Compass Therapeutics (CMPX) United States $0.939B 0.00
Erasca (ERAS) United States $0.933B 0.00
YD Bio (YDES) $0.914B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.896B 0.00
Rapt Therapeutics (RAPT) United States $0.889B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.885B 0.00
Rezolute (RZLT) United States $0.878B 0.00
Iovance Biotherapeutics (IOVA) United States $0.877B 0.00
LENZ Therapeutics (LENZ) United States $0.876B 0.00
Vir Biotechnology (VIR) United States $0.872B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.857B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.853B 0.00
Arbutus Biopharma (ABUS) United States $0.852B 0.00
Alumis (ALMS) United States $0.818B 0.00
Arvinas (ARVN) United States $0.814B 0.00
CorMedix Inc (CRMD) United States $0.813B 7.53
Geron (GERN) United States $0.811B 0.00
Replimune (REPL) United States $0.810B 0.00
Gossamer Bio (GOSS) United States $0.792B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
GH Research (GHRS) Ireland $0.748B 0.00
Astria Therapeutics (ATXS) United States $0.747B 0.00
Gyre Therapeutics (GYRE) United States $0.736B 95.50
BGM Group (BGM) China $0.736B 0.00
MapLight Therapeutics (MPLT) United States $0.701B 0.00
Cytek Biosciences (CTKB) United States $0.685B 0.00
Myriad Genetics (MYGN) United States $0.683B 0.00
CytomX Therapeutics (CTMX) United States $0.678B 10.00
Verastem (VSTM) United States $0.672B 0.00
MeiraGTx Holdings (MGTX) United States $0.654B 0.00
REGENXBIO (RGNX) United States $0.652B 0.00
Prime Medicine (PRME) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Evommune (EVMN) $0.638B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.630B 0.00
Cullinan Therapeutics (CGEM) United States $0.620B 0.00
Emergent Biosolutions (EBS) United States $0.609B 5.86
Prothena (PRTA) Ireland $0.601B 0.00
Bright Minds Biosciences (DRUG) United States $0.577B 0.00
Inventiva S.A (IVA) France $0.576B 0.00
Ventyx Biosciences (VTYX) United States $0.559B 0.00
Design Therapeutics (DSGN) United States $0.557B 0.00
Jade Biosciences (JBIO) United States $0.552B 0.00
Keros Therapeutics (KROS) United States $0.551B 11.75
Ginkgo Bioworks Holdings (DNA) United States $0.546B 0.00
Niagen Bioscience (NAGE) United States $0.521B 40.81
Invivyd (IVVD) United States $0.520B 0.00
EnGene Holdings (ENGN) Canada $0.517B 0.00
Monopar Therapeutics (MNPR) United States $0.516B 0.00
Annexon (ANNX) United States $0.512B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.509B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.495B 0.00
Absci (ABSI) United States $0.495B 0.00
Fulcrum Therapeutics (FULC) United States $0.490B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.489B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.475B 0.00
DBV Technologies S.A (DBVT) France $0.467B 0.00
NovaBridge Biosciences (NBP) United States $0.444B 0.00
DiaMedica Therapeutics (DMAC) United States $0.443B 0.00
Eton Pharmaceuticals (ETON) United States $0.442B 0.00
Immuneering (IMRX) United States $0.435B 0.00
Benitec Biopharma (BNTC) United States $0.426B 0.00
Alto Neuroscience (ANRO) United States $0.416B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.411B 0.00
Anavex Life Sciences (AVXL) United States $0.408B 0.00
Kamada (KMDA) Israel $0.408B 19.69
PureTech Health (PRTC) United States $0.406B 0.00
Solid Biosciences (SLDB) United States $0.404B 0.00
Aura Biosciences (AURA) United States $0.400B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.394B 0.00
Entrada Therapeutics (TRDA) United States $0.385B 0.00
XOMA Royalty (XOMA) United States $0.384B 0.00
Neumora Therapeutics (NMRA) United States $0.379B 0.00
Tectonic Therapeutic (TECX) United States $0.378B 0.00
Ocugen (OCGN) United States $0.378B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.361B 0.00
PepGen (PEPG) United States $0.361B 0.00
Northwest Biotherapeutics (NWBO) United States $0.356B 0.00
Allogene Therapeutics (ALLO) United States $0.342B 0.00
Amarin (AMRN) Ireland $0.339B 0.00
BioAge Labs (BIOA) United States $0.331B 0.00
Contineum Therapeutics (CTNM) United States $0.325B 0.00
Kyverna Therapeutics (KYTX) United States $0.314B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.312B 0.00
Neurogene (NGNE) United States $0.312B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.311B 0.00
GENFIT S.A (GNFTY) France $0.292B 0.00
Lifecore Biomedical (LFCR) United States $0.286B 0.00
AC Immune (ACIU) Switzerland $0.286B 0.00
X4 Pharmaceuticals (XFOR) United States $0.284B 0.00
Candel Therapeutics (CADL) United States $0.276B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.274B 0.00
C4 Therapeutics (CCCC) United States $0.272B 0.00
Nautilus Biotechnology (NAUT) United States $0.263B 0.00
Puma Biotechnology (PBYI) United States $0.262B 7.01
Aardvark Therapeutics (AARD) United States $0.260B 0.00
Adherex Technologies (FENC) United States $0.258B 0.00
Alpha Teknova (TKNO) United States $0.257B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 4.19
Palisade Bio (PALI) United States $0.252B 0.00
Foghorn Therapeutics (FHTX) United States $0.251B 0.00
Prima BioMed (IMMP) Australia $0.250B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.242B 0.00
Humacyte (HUMA) United States $0.242B 0.00
Atea Pharmaceuticals (AVIR) United States $0.241B 0.00
Cabaletta Bio (CABA) United States $0.241B 0.00
Zura Bio (ZURA) United States $0.239B 0.00
Voyager Therapeutics (VYGR) United States $0.235B 0.00
Editas Medicine (EDIT) United States $0.231B 0.00
Forte Biosciences (FBRX) United States $0.229B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.223B 0.00
Tenaya Therapeutics (TNYA) United States $0.221B 0.00
SELLAS Life Sciences (SLS) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.214B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.211B 0.00
Sagimet Biosciences (SGMT) United States $0.210B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.197B 0.00
Rani Therapeutics Holdings (RANI) United States $0.197B 0.00
Quince Therapeutics (QNCX) United States $0.196B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.187B 0.00
Crescent Biopharma (CBIO) United States $0.186B 0.00
Molecular Partners AG (MOLN) Switzerland $0.180B 0.00
Genelux (GNLX) United States $0.177B 0.00
SAB Biotherapeutics (SABS) United States $0.176B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.174B 0.00
Cartesian Therapeutics (RNAC) United States $0.173B 0.00
Actuate Therapeutics (ACTU) United States $0.173B 0.00
Sangamo Therapeutics (SGMO) United States $0.168B 0.00
Shattuck Labs (STTK) United States $0.165B 0.00
Nuvectis Pharma (NVCT) United States $0.163B 0.00
MaxCyte (MXCT) United States $0.162B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.160B 0.00
Cognition Therapeutics (CGTX) United States $0.159B 0.00
Seres Therapeutics (MCRB) United States $0.158B 0.00
Black Diamond Therapeutics (BDTX) United States $0.153B 7.47
Codexis (CDXS) United States $0.153B 0.00
CAMP4 Therapeutics (CAMP) United States $0.152B 0.00
Scilex Holding (SCLX) United States $0.151B 0.00
Connect Biopharma Holdings (CNTB) United States $0.148B 0.00
Coherus Oncology (CHRS) United States $0.147B 0.00
VistaGen Therapeutics (VTGN) United States $0.147B 0.00
Opus Genetics (IRD) United States $0.144B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
Agenus (AGEN) United States $0.142B 0.00
Elicio Therapeutics (ELTX) United States $0.141B 0.00
Compugen (CGEN) Israel $0.140B 0.00
Immix Biopharma (IMMX) United States $0.139B 0.00
Mersana Therapeutics (MRSN) United States $0.139B 0.00
Anika Therapeutics (ANIK) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.135B 0.00
Coya Therapeutics (COYA) United States $0.129B 0.00
Spero Therapeutics (SPRO) United States $0.128B 0.00
Nkarta (NKTX) United States $0.126B 0.00
Alpha Cognition (ACOG) Canada $0.126B 0.00
EXoZymes (EXOZ) United States $0.126B 0.00
Fate Therapeutics (FATE) United States $0.125B 0.00
Alector (ALEC) United States $0.124B 0.00
Annovis Bio (ANVS) United States $0.123B 0.00
Turn Therapeutics (TTRX) United States $0.120B 0.00
Climb Bio (CLYM) United States $0.119B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.117B 0.00
Greenwich LifeSciences (GLSI) United States $0.117B 0.00
Ovid Therapeutics (OVID) United States $0.113B 0.00
BioHarvest Sciences (BHST) Canada $0.107B 0.00
Whitehawk Therapeutics (WHWK) United States $0.106B 0.00
Seer (SEER) United States $0.105B 0.00
Kalaris Therapeutics (KLRS) United States $0.104B 0.00
Citius Oncology (CTOR) United States $0.102B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.102B 0.00
VTv Therapeutics (VTVT) United States $0.102B 0.00
Starpharma Holdings (SPHRY) Australia $0.100B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.100B 0.00
Chrome Holding (MEHCQ) United States $0.099B 0.00
TuHURA Biosciences (HURA) United States $0.098B 0.00
Adagene (ADAG) China $0.097B 0.00
Spruce Biosciences (SPRB) United States $0.097B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.096B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.095B 0.00
Pliant Therapeutics (PLRX) United States $0.095B 0.00
Entera Bio (ENTX) Israel $0.094B 0.00
Repare Therapeutics (RPTX) Canada $0.093B 0.00
Adverum Biotechnologies (ADVM) United States $0.092B 0.00
Oncolytics Biotech (ONCY) Canada $0.091B 0.00
Atara Biotherapeutics (ATRA) United States $0.090B 5.76
Vor Biopharma (VOR) $0.089B 0.00
Artiva Biotherapeutics (ARTV) United States $0.088B 0.00
Oncobiologics (OTLK) United States $0.088B 0.00
Tharimmune (THAR) United States $0.087B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.085B 0.00
Tevogen Bio Holdings (TVGN) United States $0.085B 0.00
Fortress Biotech (FBIO) United States $0.083B 0.00
Adicet Bio (ACET) United States $0.082B 0.00
XBiotech (XBIT) United States $0.079B 0.00
Immunic (IMUX) United States $0.078B 0.00
Instil Bio (TIL) United States $0.078B 0.00
BeyondSpring (BYSI) United States $0.077B 0.00
CervoMed (CRVO) United States $0.077B 0.00
ATyr Pharma (ATYR) United States $0.076B 0.00
Clene (CLNN) United States $0.075B 0.00
Biomea Fusion (BMEA) United States $0.074B 0.00
ImageneBio (IMA) United States $0.074B 0.00
Sutro Biopharma (STRO) United States $0.074B 0.00
BioStem Technologies (BSEM) $0.073B 5.11
ALX Oncology Holdings (ALXO) United States $0.072B 0.00
InflaRx (IFRX) Germany $0.068B 0.00
CalciMedica (CALC) United States $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Estrella Immunopharma (ESLA) United States $0.065B 0.00
OKYO Pharma (OKYO) $0.065B 0.00
ABVC BioPharma (ABVC) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.061B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.060B 0.00
TScan Therapeutics (TCRX) United States $0.058B 0.00
Senti Biosciences (SNTI) United States $0.058B 0.00
Tenax Therapeutics (TENX) United States $0.057B 0.00
Celularity (CELU) United States $0.057B 0.00
Equillium (EQ) United States $0.053B 0.00
Femasys (FEMY) United States $0.052B 0.00
MiNK Therapeutics (INKT) United States $0.051B 0.00
Adlai Nortye (ANL) Cayman Islands $0.050B 0.00
Grace Therapeutics (GRCE) United States $0.049B 0.00
BioAtla (BCAB) United States $0.049B 0.00
INmune Bio (INMB) United States $0.047B 0.00
TELA Bio (TELA) United States $0.046B 0.00
Jasper Therapeutics (JSPR) United States $0.046B 0.00
IO Biotech (IOBT) Denmark $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.046B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
Cue Biopharma (CUE) United States $0.044B 0.00
Q32 Bio (QTTB) United States $0.044B 0.00
BioXcel Therapeutics (BTAI) United States $0.042B 0.00
PDS Biotechnology (PDSB) United States $0.042B 0.00
Radiopharm Theranostics - (RADX) Australia $0.042B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Skye Bioscience (SKYE) United States $0.039B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
Quantum Biopharma (QNTM) Canada $0.038B 0.00
Medicus Pharma (MDCX) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Rein Therapeutics (RNTX) United States $0.036B 0.00
Genenta Science S.p.A (GNTA) Italy $0.036B 0.00
OnKure Therapeutics (OKUR) United States $0.036B 0.00
Exicure (XCUR) United States $0.035B 0.00
Generation Bio (GBIO) United States $0.035B 0.00
Dyadic (DYAI) United States $0.034B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
NextCure (NXTC) United States $0.032B 0.00
Pluri (PLUR) Israel $0.032B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Applied Therapeutics (APLT) United States $0.030B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.030B 0.00
Galecto (GLTO) Denmark $0.029B 0.00
AN2 Therapeutics (ANTX) United States $0.029B 0.00
Hyperion DeFi (HYPD) United States $0.029B 0.00
Rallybio (RLYB) United States $0.028B 0.00
Elutia (ELUT) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Cingulate (CING) United States $0.027B 0.00
Black Titan (BTTC) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.026B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Lexaria Bioscience (LEXX) Canada $0.025B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.024B 0.00
IBio (IBIO) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Neuphoria Therapeutics (NEUP) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.022B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Moleculin Biotech (MBRX) United States $0.015B 0.00
Chemomab Therapeutics (CMMB) Israel $0.015B 0.00
Apollomics (APLM) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
BioCardia (BCDA) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.014B 0.00
Dogwood Therapeutics (DWTX) United States $0.014B 0.00
FibroBiologics (FBLG) United States $0.014B 0.00
Longeveron (LGVN) United States $0.014B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.013B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.011B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Beyond Air (XAIR) United States $0.009B 0.00
Pasithea Therapeutics (KTTA) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Advanced Biomed (ADVB) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
KALA BIO (KALA) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Revelation Biosciences (REVB) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Alps Group (ALPS) United States $0.004B 3.24
Scinai Immunotherapeutics (SCNI) Israel $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00